Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07638995 · ClinicalTrials.gov registry record
Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction
A clinical trial, sponsored by Northwell Health.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07638995: Recruiting study, sponsored by Northwell Health.
NCT07638995 is a clinical trial that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07638995 is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The study aims to evaluate the following: 1) the incidence of new onset atrial fibrillation in patients with an atrial leadless pacemaker, 2) the need for upgrade from a standalone atrial leadless pacemaker to a dual chamber leadless pacemaker system, and 3) to compare the battery longevity of the Aveir AR at two years with the battery longevity of subjects implanted with dual chamber leadless pacemakers in the Aveir DR i2i study.
Primary Outcome
Incidence of atrial fibrillation in patients implanted with a single chamber (Aveir AR, Abbott) leadless pacemaker and a loop recorder.
Interventions
- DEVICE Implantable Loop Recorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05-18 |
| Est. Completion | 2029-12-31 |
What NCT07638995 shows while recruiting
NCT07638995 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Implantable Loop Recorder is the first listed.
NCT07638995 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07638995 about?
NCT07638995 is a clinical study titled "Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction". The study aims to evaluate the following: 1) the incidence of new onset atrial fibrillation in patients with an atrial leadless pacemaker, 2) the need for upgrade from a standalone atrial leadless pacemaker to a dual chamber leadless pacemaker system, and 3) to compare the battery longevity of the A...
What is the current status of trial NCT07638995?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-05-18. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07638995?
The interventions under investigation include: Implantable Loop Recorder (DEVICE).
Who is sponsoring clinical trial NCT07638995?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI